Literature DB >> 25999445

Maintenance rituximab every 2 months is more toxic than every 3 months in patients with non-Hodgkin lymphoma.

Armin Rashidi1, Eunhye Oak1, Nancy L Bartlett1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25999445     DOI： 10.1182/blood-2015-02-628362

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  3 in total

1.  Maintenance rituximab following induction R-CHOP chemotherapy in patients with composite or discordant, indolent and aggressive, B-cell non-Hodgkin lymphomas.

Authors:  Roopesh Kansara; Joseph M Connors; Kerry J Savage; Alina S Gerrie; David W Scott; Graham W Slack; Randy D Gascoyne; Laurie H Sehn; Diego Villa
Journal:  Haematologica       Date:  2016-06-16       Impact factor: 9.941

Review 2.  Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis: all roads lead to Rome.

Authors:  Jesus Castro-Marrero; Naia Sáez-Francàs; Dafna Santillo; Jose Alegre
Journal:  Br J Pharmacol       Date:  2017-02-01       Impact factor: 8.739

3.  Survival Outcomes of Patients with Follicular Lymphoma after Relapse or Progression: A Single-Center Real-World Data Analysis.

Authors:  Yong-Pyo Lee; Min-Sang Lee; Sang Eun Yoon; Junhun Cho; Yeong Hak Bang; Joon Ho Shim; Won Seog Kim; Seok Jin Kim
Journal:  J Oncol       Date:  2022-09-26       Impact factor: 4.501
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.